(0)サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1356795

自己免疫性肝炎の診断と治療市場レポート：2030年までの動向、予測、競合分析

Autoimmune Hepatitis Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

自己免疫性肝炎の診断と治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自己免疫性肝炎の診断と治療の動向と予測

世界の自己免疫性肝炎診断・治療市場は、2024年から2030年までのCAGRが5.3%で、2030年までに推定3億米ドルに達すると予測されます。この市場の主な促進要因は、自己免疫性肝炎の有病率の増加、ヘルスケアインフラへの投資の増加、診断ツールの改善と技術の進歩です。世界の自己免疫性肝炎診断・治療市場の将来は、病院・診療所、診断センター、研究機関市場において有望です。

自己免疫性肝炎の診断と治療市場の洞察

Lucintel社は、疾病の早期発見に対する要求の高まり、臨床応用の拡大、慢性疾患を患う高齢者人口の急増により、画像検査が予測期間中に最も高い成長を遂げると予測しています。

この市場の中では、病院と診療所が最大のセグメントであり続けると思われます。

北米は、アルコール消費量の増加、違法薬物の使用、肝疾患患者の急増、政府機関および民間団体による啓発キャンペーンの増加により、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるのか？
  • Q.1.1.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の自己免疫性肝炎の診断および治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の自己免疫性肝炎の診断および治療市場動向（2018-2023）および予測（2024-2030）
  • タイプ別の世界の自己免疫性肝炎の診断および治療市場
    • タイプI
    • タイプⅡ
    • バリアント AIH
  • 診断別の世界の自己免疫性肝炎の診断および治療市場
    • 血液検査
    • 画像検査
    • 肝生検
  • 治療別の世界の自己免疫性肝炎の診断および治療市場
    • 薬
    • コルチコステロイド
    • 免疫系抑制剤
    • 肝臓移植
  • 最終用途産業別の世界の自己免疫性肝炎の診断および治療市場
    • 病院とクリニック
    • 診断センター
    • 調査機関
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の自己免疫性肝炎の診断および治療市場
  • 北米の自己免疫性肝炎の診断および治療市場
  • 欧州の自己免疫性肝炎の診断および治療市場
  • アジア太平洋自己免疫性肝炎の診断および治療市場
  • その他地域自己免疫性肝炎の診断および治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の自己免疫性肝炎の診断および治療市場の成長機会
    • 診断別の世界の自己免疫性肝炎の診断および治療市場の成長機会
    • 治療別の世界の自己免疫性肝炎の診断および治療市場の成長機会
    • 最終用途産業別の世界の自己免疫性肝炎の診断および治療市場の成長機会
    • 地域別の世界の自己免疫性肝炎の診断および治療市場の成長機会
  • 世界の自己免疫性肝炎の診断および治療市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の自己免疫性肝炎の診断および治療市場の能力拡大
    • 世界の自己免疫性肝炎の診断および治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Abbott Laboratories
  • AbbVie
  • Arihantanam Life Care
  • AstraZeneca PLC
  • Bayer
  • Biocon
  • Bio-Rad Laboratories
  • Bristol-Myers Squibb
  • Cipla
目次

Autoimmune Hepatitis Diagnosis and Treatment Trends and Forecast

The future of the global autoimmune hepatitis diagnosis and treatment market looks promising with opportunities in the hospital & clinic, diagnostic centre, and research institution markets. The global autoimmune hepatitis diagnosis and treatment market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are increase in the prevalence of autoimmune hepatitis, rise investment for healthcare infrastructure ,and improved diagnostic tools and technological advancements.

A more than 150-page report is developed to help in your business decisions.

Autoimmune Hepatitis Diagnosis and Treatment by Segment

The study includes a forecast for the global autoimmune hepatitis diagnosis and treatment by type, diagnosis, treatment, end use industry, and region.

Autoimmune Hepatitis Diagnosis and Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Type-I
  • Type-II
  • Variant AIH

Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Blood Test
  • Imaging Test
  • Liver Biopsy

Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Medication
  • Corticosteroids
  • Immune System Suppressors
  • Liver Transplant

Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Centre
  • Research Institutions
  • Others

Autoimmune Hepatitis Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Autoimmune Hepatitis Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autoimmune hepatitis diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autoimmune hepatitis diagnosis and treatment companies profiled in this report include-

  • Abbott Laboratories
  • Abbvie
  • Arihantanam Life Care
  • Astrazeneca Plc
  • Bayer
  • Biocon
  • Bio-Rad Laboratories
  • Bristol-Myers Squibb
  • Cipla

Autoimmune Hepatitis Diagnosis and Treatment Market Insights

Lucintel forecasts that imaging test is expected to witness highest growth over the forecast period due to the increasing requirement for early disease detection, an expanding range of clinical applications, and the rapidly growing elderly population afflicted by chronic ailments.

Within this market, hospitals & clinics will remain the largest segment.

North America will remain the largest region over the forecast period due to heightened alcohol consumption, illicit drug use, a surge in liver disease cases, and growing awareness campaigns conducted by both governmental and private organizations.

Features of the Global Autoimmune Hepatitis Diagnosis and Treatment Market

Market Size Estimates: Autoimmune hepatitis diagnosis and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Autoimmune hepatitis diagnosis and treatment market by various segments, such as by type, diagnosis, treatment, end use industry and region in terms of($B).

Regional Analysis: Autoimmune hepatitis diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end use industries, and region.s for the autoimmune hepatitis diagnosis and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autoimmune hepatitis diagnosis and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the autoimmune hepatitis diagnosis and treatment market size?

Answer: The global autoimmune hepatitis diagnosis and treatment market is expected to reach an estimated $0.3 billion by 2030.

Q.2. What is the growth forecast for autoimmune hepatitis diagnosis and treatment market?

Answer: The global autoimmune hepatitis diagnosis and treatment market is expected to grow with a CAGR of 5.3% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the autoimmune hepatitis diagnosis and treatment market?

Answer: The major drivers for this market are increase in the prevalence of autoimmune hepatitis, rise investment for healthcare infrastructure, and improved diagnostic tools and technological advancements.

Q.4. What are the major segments for autoimmune hepatitis diagnosis and treatment market?

Answer: The future of the autoimmune hepatitis diagnosis and treatment market looks promising with opportunities in the hospital & clinic, diagnostic centre, and research institution markets.

Q.5. Who are the key Autoimmune Hepatitis Diagnosis and Treatment Market companies?

Answer: Some of the key autoimmune hepatitis diagnosis and treatment companies are as follows:

  • Abbott Laboratories
  • AbbVie
  • Arihantanam Life Care
  • AstraZeneca PLC
  • Bayer
  • Biocon
  • Bio-Rad Laboratories
  • Bristol-Myers Squibb
  • Cipla

Q.6. Which autoimmune hepatitis diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that imaging test is expected to witness highest growth over the forecast period due to the increasing requirement for early disease detection, an expanding range of clinical applications, and the rapidly growing elderly population afflicted by chronic ailments.

Q.7. In autoimmune hepatitis diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to heightened alcohol consumption, illicit drug use, a surge in liver disease cases, and growing awareness campaigns conducted by both governmental and private organizations.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the autoimmune hepatitis diagnosis and treatment market by type (type-I, type-II, and variant AIH), diagnosis (blood test, imaging test, and liver biopsy), treatment (medication, corticosteroids, immune system suppressors, and liver transplant), end use industry (hospitals & clinics, diagnostic centre, research institutions, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.1. 1. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Autoimmune Hepatitis Diagnosis and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Autoimmune Hepatitis Diagnosis and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type
    • 3.3.1: Type-I
    • 3.3.2: Type-II
    • 3.3.3: Variant AIH
  • 3.4: Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis
    • 3.4.1: Blood Test
    • 3.4.2: Imaging Test
    • 3.4.3: Liver Biopsy
  • 3.5: Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment
    • 3.5.1: Medication
    • 3.5.2: Corticosteroids
    • 3.5.3: Immune System Suppressors
    • 3.5.4: Liver Transplant
  • 3.6: Global Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Diagnostic Centre
    • 3.6.3: Research Institutions
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Autoimmune Hepatitis Diagnosis and Treatment Market by Region
  • 4.2: North American Autoimmune Hepatitis Diagnosis and Treatment Market
    • 4.2.1: North American Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis: Blood Test, Imaging Test, and Liver Biopsy
    • 4.2.2: North American Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry: Hospitals & Clinics, Diagnostic Centre, Research Institutions, and Others
  • 4.3: European Autoimmune Hepatitis Diagnosis and Treatment Market
    • 4.3.1: European Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis: Blood Test, Imaging Test, and Liver Biopsy
    • 4.3.2: European Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry: Hospitals & Clinics, Diagnostic Centre, Research Institutions, and Others
  • 4.4: APAC Autoimmune Hepatitis Diagnosis and Treatment Market
    • 4.4.1: APAC Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis: Blood Test, Imaging Test, and Liver Biopsy
    • 4.4.2: APAC Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry: Hospitals & Clinics, Diagnostic Centre, Research Institutions, and Others
  • 4.5: ROW Autoimmune Hepatitis Diagnosis and Treatment Market
    • 4.5.1: ROW Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis: Blood Test, Imaging Test, and Liver Biopsy
    • 4.5.2: ROW Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry: Hospitals & Clinics, Diagnostic Centre, Research Institutions, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Autoimmune Hepatitis Diagnosis and Treatment Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Autoimmune Hepatitis Diagnosis and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Autoimmune Hepatitis Diagnosis and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Autoimmune Hepatitis Diagnosis and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autoimmune Hepatitis Diagnosis and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: AbbVie
  • 7.3: Arihantanam Life Care
  • 7.4: AstraZeneca PLC
  • 7.5: Bayer
  • 7.6: Biocon
  • 7.7: Bio-Rad Laboratories
  • 7.8: Bristol-Myers Squibb
  • 7.9: Cipla